340B Protection and Accountability Act of 2019
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
51pct
1d open
vs 9,062 other HR bills in the 116th — cohort avg 39d
340B Protection and Accountability Act of 2019 This bill makes various changes to the 340B prescription drug pricing program, including requiring certain participants to pay annual user fees and requiring certain participants to establish sliding scales for the amounts they charge low-income individuals for outpatient drugs.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (6)
2020 · fourth_quarter · Medicare/Medicaid
Referred to the Subcommittee on Health.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Discussions regarding the Centers for Medicare and Medicaid (CMS) implementation and expansion of the Accelerated and Advance Payments Program under the CARES Act HR 1384 Medicare for All Act of 2019 (all sections of full text)(oppose) Disproportionate Share Hospital payments (DSH) extensions for qualifying hospitals in spending bills Discussions involving Medicare bad debt/uncompensated care payments to hospitals Discussions pertaining to status of Tennessee's Medicaid Block Grant waiver application Monitored CMS Medicaid Fiscal Accountability Regulation (MFAR) rulemaking activity Monitored S 4329 Patient Access to Higher Quality Health Care Act of 2019 Monitored HR 3062 Patient Access to Higher Quality Health Care Act of 2019 Monitored S 2543 Prescription Drug Pricing Reduction Act, Sec. 109 Monitored HR 2000 Medicare-X Choice Act of 2019 Monitored S 981 Medicare-X Choice Act of 2019 Monitored S 470 Medicare at 50 Act Monitored HR 1301 The Mental Health Telemedicine Expansion Act of 2019 Monitored HR 1559 The 340B Protection and Accountability Act of 2019 Monitored CMS regulations and reporting requirements under the Emergency Medical Treatment and Labor Act
Client expense: Not reported · Firm income: $130,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2020 · fourth_quarter · Health Issues
Proposed changes to Medicare hospital reimbursement policy Health care policy Proposals to strengthen the health care system and achieve Affordable Care Act (ACA) market stability H.R. 269, "Pandemic and All-Hazards Preparedness & Advancing Innovation Act" - provisions related to hospitals Funding for National Ebola Network H.R. 2113, Prescription Drug Sunshine, Transparency, Accountability and Reporting (STAR) Act" - provisions related to studying rising hospital drug prices and reporting of drug costs H.R. 965/S. 340, CREATES Act S. 2543, the Prescription Drug Pricing Reduction Act H.R. 3, "Elijah E. Cummings Lower Drug Costs Now Act" Additional legislative proposals to address rising drug costs H.R. 1559, "340B Protection and Accountability Act" Additional legislative proposals modifying the 340B program Surprise Billing S. 1895, Lower health Care Cost Act" H.R. 3630, "No Surprises Act" S. 1531, "STOP Surprise Medical Bills Act" H.R.5826, Consumer Protections Against Surprise Medical Bills Act of 2020 H.R. 925, Health and Economic Recovery Omnibus Emergency Solutions Act (HEROS Act 2.0) H.R. 133, "Consolidated Appropriations Act, 2021" - provisions related to combating COVID, surprise medical bills and health programs Legislative proposals aimed at combating coronavirus
Client expense: Not reported · Firm income: $110,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Health Issues
Continued implementation of ACA Health care policy H.R. 2113, Prescription Drug Sunshine, Transparency, Accountability and Reporting (STAR) Act" - provisions related to studying rising hospital drug prices and reporting of drug costs H.R. 965/S. 340, CREATES Act H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act S.2543, the Prescription Drug Pricing Reduction Act Additional legislative proposals to address rising drug costs H.R. 1559, "340B Protection and Accountability Act" Additional legislative proposals modifying the 340B program S. 1895, Lower Health Care Cost Act"- provisions related to surprise billing and payer/provider contracts S. 1531, "STOP Surprise Medical Bills Act" H.R. 3630, "No Surprises Act" H.R. 3502, "Protecting People from Surprise Medical Bills Act" H.R.5826, "Consumer Protections Against Surprise Medical Bills Act of 2020" H.R. 925, Health and Economic Recovery Omnibus Emergency Solutions Act (HEROS Act 2.0) H.R. 133, "Consolidated Appropriations Act, 2021" - provisions related to federal financial relief, including funding for healthcare providers, and health programs and related to surprise medical bills Legislative proposals aimed at combating coronavirus
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Health Issues
Health care payment and delivery system reform Health information technology and implementation of EHR meaningful use Policy related to health exchange risk corridors and cost-sharing reduction payments H.R. 269, "Pandemic and All-Hazards Preparedness& Advancing Innovation Act" - provisions related to hospitals H.R. 2113, Prescription Drug Sunshine, Transparency, Accountability and Reporting (STAR) Act" - provisions related to studying rising hospital drug prices and reporting of drug costs H.R. 965/S.340, CREATES Act S. 2543, the Prescription Drug Pricing Reduction Act H.R. 3, "Elijah E. Cummings Lower Drug Costs Now Act" Additional legislative proposals to address rising drug costs S. 1895, Lower Health Care Cost Act"- provisions related to surprise billing and payer/provider contracts S. 1531, "STOP Surprise Medical Bills Act" H.R. 3630 "No Surprises Act" H.R.5826, "Consumer Protections Against Surprise Medical Bills Act of 2020" H.R. 1559, "340B Protection and Accountability Act" Additional legislative proposals modifying the 340B program H.R. 925, Health and Economic Recovery Omnibus Emergency Solutions Act (HEROS Act 2.0) H.R. 133, "Consolidated Appropriations Act, 2021" - provisions related to federal financial relief, including funding for healthcare providers, health programs and surprise medical billing Legislative proposals aimed at combating coronavirus
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Health Issues
Health care policy H.R. 1559, "340B Protection and Accountability Act" Additional legislative proposals modifying the 340B program H.R. 925, Health and Economic Recovery Omnibus Emergency Solutions Act (HEROS Act 2.0) H.R. 133, "Consolidated Appropriations Act, 2021" - provisions aimed at addressing COVID Legislative proposals aimed at combating coronavirus
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Health Issues
Proposed changes to Medicare hospital reimbursement policy Health care policy H.R. 986/S. 466 Protecting Americans with Preexisting Conditions Act of 2019, a bill provide that certain guidance related to waivers for State innovation under the ACA shall have no force or effect H.R. 2113, Prescription Drug Sunshine, Transparency, Accountability and Reporting (STAR) Act" - provisions related to studying rising hospital drug prices and reporting of drug costs H.R. 965/S. 340, "CREATES Act" H.R. 938, Bringing Low-cost Options and Competition while Keeping Incentives for New Generics Act of 2019 or the BLOCKING Act of 2019 - provisions related to eligibility for approval of a subsequent generic drug and to remove the barrier to that approval posed by the 180-day exclusivity period afforded to a first generic applicant that has not yet received final approval H.R. 1499 Protecting Consumer Access to Generic Drugs Act of 2019 - provisions related to prohibiting brand name drug manufacturers from compensating generic drug manufacturers to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable product manufacturers to delay entry of biosimilar and interchangeable products S. 2543, the Prescription Drug Pricing Reduction Act H.R. 3, "Elijah E. Cummings Lower Drug Costs Now Act" Additional legislative proposals to address rising drug costs H.R. 1559, "340B Protection and Accountability Act" Additional legislative proposals modifying the 340B program S.1895, Lower Health Care Costs Act- provisions related to surprise billing and provider/payer agreements S. 1531, "STOP Surprise Medical Bills Act" H.R. 3630, "No Surprises Act" H.R.5826, "Consumer Protections Against Surprise Medical Bills Act of 2020" Other proposals to address surprise billing Proposals to strengthen the health care system and achieve ACA market stability Legislation aimed at combating COVID-19 - provisions related to healthcare and hospitals H.R. 925, "Health and Economic Recovery Omnibus Emergency Solutions Act (HEROS Act 2.0) H.R. 133, "Consolidated Appropriations Act, 2021" - provisions related to COVID-response and hospitals Legislative proposals aimed at combating coronavirus
Client expense: Not reported · Firm income: $50,000
2020 · fourth_quarter · Health Issues
Funding for hospitals and physicians related to COVID 19 Proposed changes to Medicare hospital reimbursement policy Health care policy Proposals to strengthen the health care system and achieve Affordable Care Act (ACA) market stability 42 CFR Part 2 alignment with HIPAA H.R. 269, "Pandemic and All-Hazards Preparedness& Advancing Innovation Act" - provisions related to hospitals Funding for National Ebola Network H.R. 2740, FY 2020 Labor, HHS, Education appropriations - provisions providing funding to support a National Ebola Education and Training Center H.R. 2113, Prescription Drug Sunshine, Transparency, Accountability and Reporting (STAR) Act" - provisions related to studying rising hospital drug prices and reporting of drug costs H.R. 965/S. 340, CREATES Act Additional legislative proposals to address rising drug costs H.R. 1559, "340B Protection and Accountability Act" Additional legislative proposals modifying the 340B program Surprise Billing S. 1895, Lower health Care Cost Act" H.R. 3630, "No Surprises Act" S. 1531, "STOP Surprise Medical Bills Act" Paycheck Protection Program Flexibility Act of 2020
Client expense: $398,118 · Firm income: Not reported
2020 · third_quarter · Health Issues
Continued implementation of ACA Health care policy H.R. 2113, Prescription Drug Sunshine, Transparency, Accountability and Reporting (STAR) Act" - provisions related to studying rising hospital drug prices and reporting of drug costs H.R. 965/S. 340, CREATES Act H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act S.2543, the Prescription Drug Pricing Reduction Act Additional legislative proposals to address rising drug costs H.R. 1559, "340B Protection and Accountability Act" Additional legislative proposals modifying the 340B program S. 1895, Lower Health Care Cost Act"- provisions related to surprise billing and payer/provider contracts S. 1531, "STOP Surprise Medical Bills Act" H.R. 3630, "No Surprises Act" H.R. 3502, "Protecting People from Surprise Medical Bills Act" H.R.5826, "Consumer Protections Against Surprise Medical Bills Act of 2020" H.R. 748, "Coronavirus Aid, Relief, and Economic Security Act" (CARES Act) - provisions related to federal financial relief, including funding for healthcare providers, health programs and 42 CFR Part 2 Senate Health, Economic Assistance, Liability Protections and Schools (HEALS) Act H.R. 925, Health and Economic Recovery Omnibus Emergency Solutions Act (HEROS Act 2.0) Legislative proposals aimed at combating coronavirus
Client expense: Not reported · Firm income: $30,000
2020 · third_quarter · Health Issues
Health care payment and delivery system reform Health information technology and implementation of EHR meaningful use Policy related to health exchange risk corridors and cost-sharing reduction payments H.R. 269, "Pandemic and All-Hazards Preparedness& Advancing Innovation Act" - provisions related to hospitals H.R. 2113, Prescription Drug Sunshine, Transparency, Accountability and Reporting (STAR) Act" - provisions related to studying rising hospital drug prices and reporting of drug costs H.R. 965/S.340, CREATES Act S. 2543, the Prescription Drug Pricing Reduction Act H.R. 3, "Elijah E. Cummings Lower Drug Costs Now Act" Additional legislative proposals to address rising drug costs S. 1895, Lower Health Care Cost Act"- provisions related to surprise billing and payer/provider contracts S. 1531, "STOP Surprise Medical Bills Act" H.R. 3630 "No Surprises Act" H.R.5826, "Consumer Protections Against Surprise Medical Bills Act of 2020" H.R. 1559, "340B Protection and Accountability Act" Additional legislative proposals modifying the 340B program H.R. 748, "Coronavirus Aid, Relief, and Economic Security Act" (CARES Act) - provisions related to federal financial relief, including funding for healthcare providers, health programs and 42 CFR Part 2 Senate Health, Economic Assistance, Liability Protections and Schools (HEALS) Act H.R. 925, Health and Economic Recovery Omnibus Emergency Solutions Act (HEROS Act 2.0) Legislative proposals aimed at combating coronavirus
Client expense: Not reported · Firm income: $30,000
2020 · third_quarter · Health Issues
Proposed changes to Medicare hospital reimbursement policy Health care policy Proposals to strengthen the health care system and achieve Affordable Care Act (ACA) market stability H.R. 269, "Pandemic and All-Hazards Preparedness & Advancing Innovation Act" - provisions related to hospitals Funding for National Ebola Network H.R. 2113, Prescription Drug Sunshine, Transparency, Accountability and Reporting (STAR) Act" - provisions related to studying rising hospital drug prices and reporting of drug costs H.R. 965/S. 340, CREATES Act S. 2543, the Prescription Drug Pricing Reduction Act H.R. 3, "Elijah E. Cummings Lower Drug Costs Now Act" Additional legislative proposals to address rising drug costs H.R. 1559, "340B Protection and Accountability Act" Additional legislative proposals modifying the 340B program Surprise Billing S. 1895, Lower health Care Cost Act" H.R. 3630, "No Surprises Act" S. 1531, "STOP Surprise Medical Bills Act" H.R.5826, Consumer Protections Against Surprise Medical Bills Act of 2020 H.R. 748, "Coronavirus Aid, Relief, and Economic Security Act" (CARES Act) - provisions related to federal financial relief, including funding for healthcare providers, and 42 CFR Part 2 Senate Health, Economic Assistance, Liability Protections and Schools (HEALS) Act H.R. 925, Health and Economic Recovery Omnibus Emergency Solutions Act (HEROS Act 2.0) Legislative proposals aimed at combating coronavirus
Client expense: Not reported · Firm income: $110,000
2020 · third_quarter · Health Issues
Health care policy H.R. 1559, "340B Protection and Accountability Act" Additional legislative proposals modifying the 340B program H.R. 748, "Coronavirus Aid, Relief, and Economic Security Act" (CARES Act) - provisions related to federal financial relief, including funding for healthcare providers Senate Health, Economic Assistance, Liability Protections and Schools (HEALS) Act H.R. 925, Health and Economic Recovery Omnibus Emergency Solutions Act (HEROS Act 2.0) Legislative proposals aimed at combating coronavirus
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Health Issues
Proposed changes to Medicare hospital reimbursement policy Health care policy H.R. 986/S. 466 Protecting Americans with Preexisting Conditions Act of 2019, a bill provide that certain guidance related to waivers for State innovation under the ACA shall have no force or effect H.R. 2113, Prescription Drug Sunshine, Transparency, Accountability and Reporting (STAR) Act" - provisions related to studying rising hospital drug prices and reporting of drug costs H.R. 965/S. 340, "CREATES Act" H.R. 938, Bringing Low-cost Options and Competition while Keeping Incentives for New Generics Act of 2019 or the BLOCKING Act of 2019 - provisions related to eligibility for approval of a subsequent generic drug and to remove the barrier to that approval posed by the 180-day exclusivity period afforded to a first generic applicant that has not yet received final approval H.R. 1499 Protecting Consumer Access to Generic Drugs Act of 2019 - provisions related to prohibiting brand name drug manufacturers from compensating generic drug manufacturers to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable product manufacturers to delay entry of biosimilar and interchangeable products S. 2543, the Prescription Drug Pricing Reduction Act H.R. 3, "Elijah E. Cummings Lower Drug Costs Now Act" Additional legislative proposals to address rising drug costs H.R. 1559, "340B Protection and Accountability Act" Additional legislative proposals modifying the 340B program S.1895, Lower Health Care Costs Act- provisions related to surprise billing and provider/payer agreements S. 1531, "STOP Surprise Medical Bills Act" H.R. 3630, "No Surprises Act" H.R.5826, "Consumer Protections Against Surprise Medical Bills Act of 2020" Other proposals to address surprise billing Proposals to strengthen the health care system and achieve ACA market stability Legislation aimed at combating COVID-19 - provisions related to healthcare and hospitals H.R. 6201, "Families First Coronavirus Response Act" - provisions related to healthcare, Medicaid and Medicare H.R. 748, "Coronavirus Aid, Relief, and Economic Security Act" (CARES Act) - provisions related to federal financial relief, including funding for healthcare providers Senate Health, Economic Assistance, Liability Protections and Schools (HEALS) Act H.R. 925, Health and Economic Recovery Omnibus Emergency Solutions Act (HEROS Act 2.0) Legislative proposals aimed at combating coronavirus
2020 · third_quarter · Health Issues
Funding for hospitals and physicians related to COVID 19 Proposed changes to Medicare hospital reimbursement policy Health care policy Proposals to strengthen the health care system and achieve Affordable Care Act (ACA) market stability 42 CFR Part 2 alignment with HIPAA H.R. 269, "Pandemic and All-Hazards Preparedness& Advancing Innovation Act" - provisions related to hospitals Funding for National Ebola Network H.R. 2740, FY 2020 Labor, HHS, Education appropriations - provisions providing funding to support a National Ebola Education and Training Center H.R. 2113, Prescription Drug Sunshine, Transparency, Accountability and Reporting (STAR) Act" - provisions related to studying rising hospital drug prices and reporting of drug costs H.R. 965/S. 340, CREATES Act Additional legislative proposals to address rising drug costs H.R. 1559, "340B Protection and Accountability Act" Additional legislative proposals modifying the 340B program Surprise Billing S. 1895, Lower health Care Cost Act" H.R. 3630, "No Surprises Act" S. 1531, "STOP Surprise Medical Bills Act" Paycheck Protection Program Flexibility Act of 2020
Client expense: $201,000 · Firm income: Not reported
2020 · third_quarter · Medicare/Medicaid
Discussions regarding the Centers for Medicare and Medicaid (CMS) implementation and expansion of the Accelerated and Advance Payments Program under the CARES Act HR 1384 Medicare for All Act of 2019 (all sections of full text)(oppose) Disproportionate Share Hospital payments (DSH) extensions for qualifying hospitals in spending bills Discussions involving Medicare bad debt/uncompensated care payments to hospitals \ Monitored CMS Medicaid Fiscal Accountability Regulation (MFAR) rulemaking activity Monitored S 4329 Patient Access to Higher Quality Health Care Act of 2019 Monitored HR 3062 Patient Access to Higher Quality Health Care Act of 2019 Monitored S 2543 Prescription Drug Pricing Reduction Act, Sec. 109 Monitored HR 2000 Medicare-X Choice Act of 2019 Monitored S 981 Medicare-X Choice Act of 2019 Monitored S 470 Medicare at 50 Act Monitored HR 1301 The Mental Health Telemedicine Expansion Act of 2019 Monitored HR 1559 The 340B Protection and Accountability Act of 2019 Monitored CMS regulations and reporting requirements under the Emergency Medical Treatment and Labor Act
Client expense: Not reported · Firm income: $130,000
2020 · second_quarter · Health Issues
Proposed changes to Medicare hospital reimbursement policy Health care policy Proposals to strengthen the health care system and achieve Affordable Care Act (ACA) market stability 42 CFR Part 2 alignment with HIPAA H.R. 269, "Pandemic and All-Hazards Preparedness& Advancing Innovation Act" - provisions related to hospitals Funding for National Ebola Network H.R. 2740, FY 2020 Labor, HHS, Education appropriations - provisions providing funding to support a National Ebola Education and Training Center H.R. 2113, Prescription Drug Sunshine, Transparency, Accountability and Reporting (STAR) Act" - provisions related to studying rising hospital drug prices and reporting of drug costs H.R. 965/S. 340, CREATES Act S. 2543, the Prescription Drug Pricing Reduction Act H.R. 3, "Elijah E. Cummings Lower Drug Costs Now Act" Additional legislative proposals to address rising drug costs H.R. 1559, "340B Protection and Accountability Act" Additional legislative proposals modifying the 340B program Surprise Billing S. 1895, Lower health Care Cost Act" H.R. 3630, "No Surprises Act" S. 1531, "STOP Surprise Medical Bills Act" H.R.5826, Consumer Protections Against Surprise Medical Bills Act of 2020 H.R. 6201, "Families First Coronavirus Response Act" - provisions related to healthcare, Medicaid and Medicare H.R. 748, "Coronavirus Aid, Relief, and Economic Security Act" (CARES Act) - provisions related to federal financial relief, including funding for healthcare providers, and 42 CFR Part 2 H.R. 6800, "HEROES Act" Legislative proposals aimed at combating coronavirus
Client expense: Not reported · Firm income: $110,000
2020 · second_quarter · Health Issues
Continued implementation of ACA Health care policy 42 CFR Part 2 alignment with HIPAA H.R. 2113, Prescription Drug Sunshine, Transparency, Accountability and Reporting (STAR) Act" - provisions related to studying rising hospital drug prices and reporting of drug costs H.R. 965/S. 340, CREATES Act H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act S.2543, the Prescription Drug Pricing Reduction Act Additional legislative proposals to address rising drug costs H.R. 1559, "340B Protection and Accountability Act" Additional legislative proposals modifying the 340B program S. 1895, Lower Health Care Cost Act"- provisions related to surprise billing and payer/provider contracts S. 1531, "STOP Surprise Medical Bills Act" H.R. 3630, "No Surprises Act" H.R. 3502, "Protecting People from Surprise Medical Bills Act" H.R.5826, "Consumer Protections Against Surprise Medical Bills Act of 2020" H.R. 6201, "Families First Coronavirus Response Act" - provisions related to healthcare, telehealth, Medicaid and Medicare H.R. 748, "Coronavirus Aid, Relief, and Economic Security Act" (CARES Act) - provisions related to federal financial relief, including funding for healthcare providers, health programs and 42 CFR Part 2 H.R. 6800, "HEROES Act" Legislative proposals aimed at combating coronavirus
Client expense: Not reported · Firm income: $30,000
2020 · second_quarter · Health Issues
Health care payment and delivery system reform Health information technology and implementation of EHR meaningful use Policy related to health exchange risk corridors and cost-sharing reduction payments 42 CFR Part 2 alignment with HIPAA H.R. 269, "Pandemic and All-Hazards Preparedness& Advancing Innovation Act" - provisions related to hospitals H.R. 2113, Prescription Drug Sunshine, Transparency, Accountability and Reporting (STAR) Act" - provisions related to studying rising hospital drug prices and reporting of drug costs H.R. 965/S.340, CREATES Act S. 2543, the Prescription Drug Pricing Reduction Act H.R. 3, "Elijah E. Cummings Lower Drug Costs Now Act" Additional legislative proposals to address rising drug costs S. 1895, Lower Health Care Cost Act"- provisions related to surprise billing and payer/provider contracts S. 1531, "STOP Surprise Medical Bills Act" H.R. 3630 "No Surprises Act" H.R.5826, "Consumer Protections Against Surprise Medical Bills Act of 2020" H.R. 1559, "340B Protection and Accountability Act" Additional legislative proposals modifying the 340B program H.R. 6201, "Families First Coronavirus Response Act" - provisions related to healthcare, telehealth, Medicaid and Medicare H.R. 748, "Coronavirus Aid, Relief, and Economic Security Act" (CARES Act) - provisions related to federal financial relief, including funding for healthcare providers, health programs and 42 CFR Part 2 H.R. 6800, "HEROES Act" Legislative proposals aimed at combating coronavirus
Client expense: Not reported · Firm income: $30,000
2020 · second_quarter · Health Issues
Health care policy H.R. 1559, "340B Protection and Accountability Act" Additional legislative proposals modifying the 340B program H.R. 6201, "Families First Coronavirus Response Act" - provisions related to healthcare, Medicaid and Medicare H.R. 748, "Coronavirus Aid, Relief, and Economic Security Act" (CARES Act) - provisions related to federal financial relief, including funding for healthcare providers H.R. 6800, "HEROES Act" Legislative proposals aimed at combating coronavirus
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · second_quarter · Health Issues
Proposed changes to Medicare hospital reimbursement policy Health care policy 42 CFR Part 2 alignment with HIPAA H.R. 986/S. 466 Protecting Americans with Preexisting Conditions Act of 2019, a bill provide that certain guidance related to waivers for State innovation under the ACA shall have no force or effect H.R. 2113, Prescription Drug Sunshine, Transparency, Accountability and Reporting (STAR) Act" - provisions related to studying rising hospital drug prices and reporting of drug costs H.R. 965/S. 340, "CREATES Act" H.R. 938, Bringing Low-cost Options and Competition while Keeping Incentives for New Generics Act of 2019 or the BLOCKING Act of 2019 - provisions related to eligibility for approval of a subsequent generic drug and to remove the barrier to that approval posed by the 180-day exclusivity period afforded to a first generic applicant that has not yet received final approval H.R. 1499 Protecting Consumer Access to Generic Drugs Act of 2019 - provisions related to prohibiting brand name drug manufacturers from compensating generic drug manufacturers to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable product manufacturers to delay entry of biosimilar and interchangeable products S. 2543, the Prescription Drug Pricing Reduction Act H.R. 3, "Elijah E. Cummings Lower Drug Costs Now Act" Additional legislative proposals to address rising drug costs H.R. 1559, "340B Protection and Accountability Act" Additional legislative proposals modifying the 340B program S.1895, Lower Health Care Costs Act- provisions related to surprise billing and provider/payer agreements S. 1531, "STOP Surprise Medical Bills Act" H.R. 3630, "No Surprises Act" H.R.5826, "Consumer Protections Against Surprise Medical Bills Act of 2020" Other proposals to address surprise billing Proposals to strengthen the health care system and achieve ACA market stability Legislation aimed at combating COVID-19 - provisions related to healthcare and hospitals H.R. 6201, "Families First Coronavirus Response Act" - provisions related to healthcare, Medicaid and Medicare H.R. 748, "Coronavirus Aid, Relief, and Economic Security Act" (CARES Act) - provisions related to federal financial relief, including funding for healthcare providers H.R. 6800, HEROES Act Legislative proposals aimed at combating coronavirus
2020 · second_quarter · Medicare/Medicaid
Discussions regarding the Centers for Medicare and Medicaid (CMS) implementation and expansion of the Accelerated and Advance Payments Program under the CARES Act HR 1384 Medicare for All Act of 2019 (all sections of full text)(oppose) Disproportionate Share Hospital payments (DSH) extensions for qualifying hospitals in spending bills Discussions pertaining to the Centers for Medicare and Medicaid (CMS) implementation and expansion of the Accelerated and Advance Payments Program under the CARES Act Monitored S 2543 Prescription Drug Pricing Reduction Act, Sec. 109 Monitored HR 3 Elijah E. Cummings Lower Drug Costs Now Act of 2019 Monitored H.R. 275 Medicare Prescription Drug Price Negotiation Act of 2019 Monitored HR 2000 Medicare-X Choice Act of 2019 Monitored S 981 Medicare-X Choice Act of 2019 Monitored S 470 Medicare at 50 Act Monitored HR 1301 The Mental Health Telemedicine Expansion Act of 2019 Monitored HR 1559 The 340B Protection and Accountability Act of 2019 Monitored HR 1332 The Fair Care Act of 2019 Monitored CMS regulations and reporting requirements under the Emergency Medical Treatment and Labor Act Monitored proposed reduction on the amount of Medicare bad debt/uncompensated care payments to hospitals for Medicare beneficiaries who fail to pay their cost-sharing obligations for treatments provided by the hospital
Client expense: Not reported · Firm income: $130,000
2020 · second_quarter · Health Issues
Funding for hospitals and physicians related to COVID 19 Proposed changes to Medicare hospital reimbursement policy Health care policy Proposals to strengthen the health care system and achieve Affordable Care Act (ACA) market stability 42 CFR Part 2 alignment with HIPAA H.R. 269, "Pandemic and All-Hazards Preparedness& Advancing Innovation Act" - provisions related to hospitals Funding for National Ebola Network H.R. 2740, FY 2020 Labor, HHS, Education appropriations - provisions providing funding to support a National Ebola Education and Training Center H.R. 2113, Prescription Drug Sunshine, Transparency, Accountability and Reporting (STAR) Act" - provisions related to studying rising hospital drug prices and reporting of drug costs H.R. 965/S. 340, CREATES Act Additional legislative proposals to address rising drug costs H.R. 1559, "340B Protection and Accountability Act" Additional legislative proposals modifying the 340B program Surprise Billing S. 1895, Lower health Care Cost Act" H.R. 3630, "No Surprises Act" S. 1531, "STOP Surprise Medical Bills Act"
Client expense: $201,000 · Firm income: Not reported
2020 · second_quarter · Health Issues
Funding for hospitals and physicians related to COVID 19 Proposed changes to Medicare hospital reimbursement policy Health care policy Proposals to strengthen the health care system and achieve Affordable Care Act (ACA) market stability 42 CFR Part 2 alignment with HIPAA H.R. 269, "Pandemic and All-Hazards Preparedness& Advancing Innovation Act" - provisions related to hospitals Funding for National Ebola Network H.R. 2740, FY 2020 Labor, HHS, Education appropriations - provisions providing funding to support a National Ebola Education and Training Center H.R. 2113, Prescription Drug Sunshine, Transparency, Accountability and Reporting (STAR) Act" - provisions related to studying rising hospital drug prices and reporting of drug costs H.R. 965/S. 340, CREATES Act Additional legislative proposals to address rising drug costs H.R. 1559, "340B Protection and Accountability Act" Additional legislative proposals modifying the 340B program Surprise Billing S. 1895, Lower health Care Cost Act" H.R. 3630, "No Surprises Act" S. 1531, "STOP Surprise Medical Bills Act"
Client expense: $201,000 · Firm income: Not reported
2020 · first_quarter · Health Issues
Funding for hospitals and physicians related to COVID 19 Proposed changes to Medicare hospital reimbursement policy Health care policy Proposals to strengthen the health care system and achieve Affordable Care Act (ACA) market stability 42 CFR Part 2 alignment with HIPAA H.R. 269, "Pandemic and All-Hazards Preparedness& Advancing Innovation Act" - provisions related to hospitals Funding for National Ebola Network H.R. 2740, FY 2020 Labor, HHS, Education appropriations - provisions providing funding to support a National Ebola Education and Training Center H.R. 2113, Prescription Drug Sunshine, Transparency, Accountability and Reporting (STAR) Act" - provisions related to studying rising hospital drug prices and reporting of drug costs H.R. 965/S. 340, CREATES Act Additional legislative proposals to address rising drug costs H.R. 1559, "340B Protection and Accountability Act" Additional legislative proposals modifying the 340B program Surprise Billing S. 1895, Lower health Care Cost Act" H.R. 3630, "No Surprises Act" S. 1531, "STOP Surprise Medical Bills Act"
Client expense: $129,472 · Firm income: Not reported
2020 · first_quarter · Health Issues
Continued implementation of ACA Health care policy 42 CFR Part 2 alignment with HIPAA H.R. 2113, Prescription Drug Sunshine, Transparency, Accountability and Reporting (STAR) Act" - provisions related to studying rising hospital drug prices and reporting of drug costs H.R. 965/S. 340, CREATES Act H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act S.2543, the Prescription Drug Pricing Reduction Act Additional legislative proposals to address rising drug costs H.R. 1559, "340B Protection and Accountability Act" Additional legislative proposals modifying the 340B program S. 1895, Lower Health Care Cost Act"- provisions related to surprise billing and payer/provider contracts S. 1531, "STOP Surprise Medical Bills Act" H.R. 3630, "No Surprises Act" H.R. 3502, "Protecting People from Surprise Medical Bills Act" House Ways and Means Committee proposal to address surprise medical bills H.R. 6201, "Families First Coronavirus Response Act" - provisions related to healthcare, telehealth, Medicaid and Medicare H.R. 748, "Coronavirus Aid, Relief, and Economic Security Act" (CARES Act) - provisions related to federal financial relief, including funding for healthcare providers, health programs and 42 CFR Part 2 Legislative proposals aimed at combating coronavirus
Client expense: Not reported · Firm income: $30,000
2020 · first_quarter · Health Issues
Health care payment and delivery system reform Health information technology and implementation of EHR meaningful use Policy related to health exchange risk corridors and cost-sharing reduction payments 42 CFR Part 2 alignment with HIPAA H.R. 269, "Pandemic and All-Hazards Preparedness& Advancing Innovation Act" - provisions related to hospitals H.R. 2113, Prescription Drug Sunshine, Transparency, Accountability and Reporting (STAR) Act" - provisions related to studying rising hospital drug prices and reporting of drug costs H.R. 965/S.340, CREATES Act S. 2543, the Prescription Drug Pricing Reduction Act H.R. 3, "Elijah E. Cummings Lower Drug Costs Now Act" Additional legislative proposals to address rising drug costs S. 1895, Lower Health Care Cost Act"- provisions related to surprise billing and payer/provider contracts S. 1531, "STOP Surprise Medical Bills Act" H.R. 3630 "No Surprises Act" House Ways and Means Committee proposal to address surprise medical bills H.R. 1559, "340B Protection and Accountability Act" Additional legislative proposals modifying the 340B program H.R. 6201, "Families First Coronavirus Response Act" - provisions related to healthcare, telehealth, Medicaid and Medicare H.R. 748, "Coronavirus Aid, Relief, and Economic Security Act" (CARES Act) - provisions related to federal financial relief, including funding for healthcare providers, health programs and 42 CFR Part 2 Legislative proposals aimed at combating coronavirus
Client expense: Not reported · Firm income: $30,000
2020 · first_quarter · Health Issues
Proposed changes to Medicare hospital reimbursement policy Health care policy Proposals to strengthen the health care system and achieve Affordable Care Act (ACA) market stability 42 CFR Part 2 alignment with HIPAA H.R. 269, "Pandemic and All-Hazards Preparedness& Advancing Innovation Act" - provisions related to hospitals Funding for National Ebola Network H.R. 2740, FY 2020 Labor, HHS, Education appropriations - provisions providing funding to support a National Ebola Education and Training Center H.R. 2113, Prescription Drug Sunshine, Transparency, Accountability and Reporting (STAR) Act" - provisions related to studying rising hospital drug prices and reporting of drug costs H.R. 965/S. 340, CREATES Act S. 2543, the Prescription Drug Pricing Reduction Act H.R. 3, "Elijah E. Cummings Lower Drug Costs Now Act" Additional legislative proposals to address rising drug costs H.R. 1559, "340B Protection and Accountability Act" Additional legislative proposals modifying the 340B program Surprise Billing S. 1895, Lower health Care Cost Act" H.R. 3630, "No Surprises Act" S. 1531, "STOP Surprise Medical Bills Act" House Ways and Means Committee proposal to address surprise medical bills H.R. 6201, "Families First Coronavirus Response Act" - provisions related to healthcare, Medicaid and Medicare H.R. 748, "Coronavirus Aid, Relief, and Economic Security Act" (CARES Act) - provisions related to federal financial relief, including funding for healthcare providers, and 42 CFR Part 2 Legislative proposals aimed at combating coronavirus
Client expense: Not reported · Firm income: $110,000
2020 · first_quarter · Health Issues
Health care policy H.R. 1559, "340B Protection and Accountability Act" Additional legislative proposals modifying the 340B program H.R. 6201, "Families First Coronavirus Response Act" - provisions related to healthcare, Medicaid and Medicare H.R. 748, "Coronavirus Aid, Relief, and Economic Security Act" (CARES Act) - provisions related to federal financial relief, including funding for healthcare providers Legislative proposals aimed at combating coronavirus
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · first_quarter · Health Issues
Proposed changes to Medicare hospital reimbursement policy Health care policy 42 CFR Part 2 alignment with HIPAA H.R. 986/S. 466 Protecting Americans with Preexisting Conditions Act of 2019, a bill provide that certain guidance related to waivers for State innovation under the ACA shall have no force or effect H.R. 2113, Prescription Drug Sunshine, Transparency, Accountability and Reporting (STAR) Act" - provisions related to studying rising hospital drug prices and reporting of drug costs H.R. 965/S. 340, "CREATES Act" H.R. 938, Bringing Low-cost Options and Competition while Keeping Incentives for New Generics Act of 2019 or the BLOCKING Act of 2019 - provisions related to eligibility for approval of a subsequent generic drug and to remove the barrier to that approval posed by the 180-day exclusivity period afforded to a first generic applicant that has not yet received final approval H.R. 1499 Protecting Consumer Access to Generic Drugs Act of 2019 - provisions related to prohibiting brand name drug manufacturers from compensating generic drug manufacturers to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable product manufacturers to delay entry of biosimilar and interchangeable products S. 2543, the Prescription Drug Pricing Reduction Act H.R. 3, "Elijah E. Cummings Lower Drug Costs Now Act" Additional legislative proposals to address rising drug costs H.R. 1559, "340B Protection and Accountability Act" Additional legislative proposals modifying the 340B program S.1895, Lower Health Care Costs Act- provisions related to surprise billing and provider/payer agreements S. 1531, "STOP Surprise Medical Bills Act" H.R. 3630, "No Surprises Act" House Ways and Means Committee proposal to address surprise medical bills Other proposals to address surprise billing Proposals to strengthen the health care system and achieve ACA market stability Legislation aimed at combating COVID-19 - provisions related to healthcare and hospitals. H.R. 6201, "Families First Coronavirus Response Act" - provisions related to healthcare, Medicaid and Medicare H.R. 748, "Coronavirus Aid, Relief, and Economic Security Act" (CARES Act) - provisions related to federal financial relief, including funding for healthcare providers Legislative proposals aimed at combating coronavirus
2020 · first_quarter · Medicare/Medicaid
HR 1384 Medicare for All Act of 2019 (all sections of full text)(oppose) Disproportionate Share Hospital payments (DSH) extensions for qualifying hospitals in spending bills Monitored S 2543 Prescription Drug Pricing Reduction Act, Sec. 109 Monitored HR 3 Elijah E. Cummings Lower Drug Costs Now Act of 2019 Monitored H.R. 275 Medicare Prescription Drug Price Negotiation Act of 2019 Monitored HR 2000 Medicare-X Choice Act of 2019 Monitored S 981 Medicare-X Choice Act of 2019 Monitored S 470 Medicare at 50 Act Monitored HR 1301 The Mental Health Telemedicine Expansion Act of 2019 Monitored HR 1559 The 340B Protection and Accountability Act of 2019 Monitored HR 1332 The Fair Care Act of 2019 Monitored CMS regulations and reporting requirements under the Emergency Medical Treatment and Labor Act Monitored proposed reduction on the amount of Medicare bad debt/uncompensated care payments to hospitals for Medicare beneficiaries who fail to pay their cost-sharing obligations for treatments provided by the hospital
Client expense: Not reported · Firm income: $130,000
2019 · fourth_quarter · Health Issues
H.R. 1559: 340B Protection and Accountability Act of 2019
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · fourth_quarter · Medicare/Medicaid
H.R. 1559: 340B Protection and Accountability Act of 2019
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · fourth_quarter · Budget/Appropriations
H.R. 1559: 340B Protection and Accountability Act of 2019
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · fourth_quarter · Medicare/Medicaid
HR1384 Medicare for All Act of 2019 (all sections of full text)(oppose) Disproportionate Share Hospital payments (DSH) extensions for qualifying hospitals in spending bills S 2543 Prescription Drug Pricing reduction Act, Sec. 109 Monitored HR 3 Elijah E. Cummings Lower Drug Costs Now Act of 2019 Monitored HR 275 Medicare Prescription Drug Price Negotiation Act of 2019 Monitored HR 2000 Medicare-X Choice Act of 2019 Monitored 981 Medicare-X Choice Act of 2019 Monitored S 470 Medicare at 50 Act Monitored HR1301 The Mental Health Telemedicine Expansion Act of 2019 Monitored HR1559 The 340B Protection and Accountability Act of 2019 Monitored HR1332 The Fair Care Act of 2019 Monitored CMS regulations and reporting requirements under the Emergency Medical Treatment and Labor Act Monitored proposed reduction on the amount of Medicare bad debt/uncompensated care payments to hospitals for Medicare beneficiaries who fail to pay their cost sharing obligations for treatments provided by the hospital
Client expense: Not reported · Firm income: $40,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2019 · fourth_quarter · Health Issues
Legislative and Administrative monitoring and outreach on issues related to health care. Legislative and Administrative monitoring and outreach on issues related to 340B programs. H.R. 1865, Further Consolidated Appropriations Act, 2020. H.R. 1559, 340B Protection and Accountability Act of 2019. H.R. 1384, Medicare for All Act of 2019. S. 1129, Medicare for All Act of 2019.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · fourth_quarter · Medicare/Medicaid
Legislative and Administrative monitoring and outreach on issues related to Medicare. Legislative and Administrative monitoring and outreach on issues related to 340B programs. H.R. 1865, Further Consolidated Appropriations Act, 2020. H.R. 1559, 340B Protection and Accountability Act of 2019. H.R. 1384, Medicare for All Act of 2019. S. 1129, Medicare for All Act of 2019.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · fourth_quarter · Health Issues
Continued implementation of ACA Health care policy 42 CFR Part 2 alignment with HIPAA H.R. 2113, Prescription Drug Sunshine, Transparency, Accountability and Reporting (STAR) Act" - provisions related to studying rising hospital drug prices and reporting of drug costs H.R. 965/S. 340, CREATES Act H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act S.2543, the Prescription Drug Pricing Reduction Act Additional legislative proposals to address rising drug costs H.R. 1559, "340B Protection and Accountability Act" Additional legislative proposals modifying the 340B program S. 1895, Lower Health Care Cost Act"- provisions related to surprise billing and payer/provider contracts S. 1531, "STOP Surprise Medical Bills Act" H.R. 3630, "No Surprises Act" H.R. 3502, "Protecting People from Surprise Medical Bills Act" House Ways and Means Committee proposal to address surprise medical bills
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · fourth_quarter · Health Issues
Health care payment and delivery system reform Health information technology and implementation of EHR meaningful use Policy related to health exchange risk corridors and cost-sharing reduction payments 42 CFR Part 2 alignment with HIPAA H.R. 269, "Pandemic and All-Hazards Preparedness& Advancing Innovation Act" - provisions related to hospitals H.R. 2113, Prescription Drug Sunshine, Transparency, Accountability and Reporting (STAR) Act" - provisions related to studying rising hospital drug prices and reporting of drug costs H.R. 965/S.340, CREATES Act S. 2543, the Prescription Drug Pricing Reduction Act H.R. 3, "Elijah E. Cummings Lower Drug Costs Now Act" Additional legislative proposals to address rising drug costs S. 1895, Lower Health Care Cost Act"- provisions related to surprise billing and payer/provider contracts S. 1531, "STOP Surprise Medical Bills Act" H.R. 3630 "No Surprises Act" House Ways and Means Committee proposal to address surprise medical bills H.R. 1559, "340B Protection and Accountability Act" Additional legislative proposals modifying the 340B program
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · fourth_quarter · Health Issues
Proposed changes to Medicare hospital reimbursement policy Health care policy Proposals to strengthen the health care system and achieve Affordable Care Act (ACA) market stability 42 CFR Part 2 alignment with HIPAA H.R. 269, "Pandemic and All-Hazards Preparedness& Advancing Innovation Act" - provisions related to hospitals Funding for National Ebola Network H.R. 2740, FY 2020 Labor, HHS, Education appropriations - provisions providing funding to support a National Ebola Education and Training Center H.R. 2113, Prescription Drug Sunshine, Transparency, Accountability and Reporting (STAR) Act" - provisions related to studying rising hospital drug prices and reporting of drug costs H.R. 965/S. 340, CREATES Act S. 2543, the Prescription Drug Pricing Reduction Act H.R. 3, "Elijah E. Cummings Lower Drug Costs Now Act" Additional legislative proposals to address rising drug costs H.R. 1559, "340B Protection and Accountability Act" Additional legislative proposals modifying the 340B program Surprise Billing S. 1895, Lower health Care Cost Act" H.R. 3630, "No Surprises Act" S. 1531, "STOP Surprise Medical Bills Act" House Ways and Means Committee proposal to address surprise medical bills
Client expense: Not reported · Firm income: $110,000
2019 · fourth_quarter · Health Issues
Health care policy H.R. 1559, "340B Protection and Accountability Act" Additional legislative proposals modifying the 340B program
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · fourth_quarter · Health Issues
Proposed changes to Medicare hospital reimbursement policy Health care policy 42 CFR Part 2 alignment with HIPAA H.R. 986/S. 466 Protecting Americans with Preexisting Conditions Act of 2019, a bill provide that certain guidance related to waivers for State innovation under the ACA shall have no force or effect H.R. 2113, Prescription Drug Sunshine, Transparency, Accountability and Reporting (STAR) Act" - provisions related to studying rising hospital drug prices and reporting of drug costs H.R. 965/S. 340, "CREATES Act" H.R. 938, Bringing Low-cost Options and Competition while Keeping Incentives for New Generics Act of 2019 or the BLOCKING Act of 2019 - provisions related to eligibility for approval of a subsequent generic drug and to remove the barrier to that approval posed by the 180-day exclusivity period afforded to a first generic applicant that has not yet received final approval H.R. 1499 Protecting Consumer Access to Generic Drugs Act of 2019 - provisions related to prohibiting brand name drug manufacturers from compensating generic drug manufacturers to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable product manufacturers to delay entry of biosimilar and interchangeable products S. 2543, the Prescription Drug Pricing Reduction Act H.R. 3, "Elijah E. Cummings Lower Drug Costs Now Act" Additional legislative proposals to address rising drug costs H.R. 1559, "340B Protection and Accountability Act" Additional legislative proposals modifying the 340B program S.1895, Lower Health Care Costs Act- provisions related to surprise billing and provider/payer agreements S. 1531, "STOP Surprise Medical Bills Act" H.R. 3630, "No Surprises Act" House Ways and Means Committee proposal to address surprise medical bills Other proposals to address surprise billing Proposals to strengthen the health care system and achieve ACA market stability
2019 · fourth_quarter · Medicare/Medicaid
HR 1384 Medicare for All Act of 2019 (all sections of full text)(oppose) Disproportionate Share Hospital payments (DSH) extensions for qualifying hospitals in spending bills S 2543 Prescription Drug Pricing Reduction Act, Sec. 109 Monitored HR 3 Elijah E. Cummings Lower Drug Costs Now Act of 2019 Monitored H.R. 275 Medicare Prescription Drug Price Negotiation Act of 2019 Monitored HR 2000 Medicare-X Choice Act of 2019 Monitored S 981 Medicare-X Choice Act of 2019 Monitored S 470 Medicare at 50 Act Monitored HR 1301 The Mental Health Telemedicine Expansion Act of 2019 Monitored HR 1559 The 340B Protection and Accountability Act of 2019 Monitored HR 1332 The Fair Care Act of 2019 Monitored CMS regulations and reporting requirements under the Emergency Medical Treatment and Labor Act Monitored proposed reduction on the amount of Medicare bad debt/uncompensated care payments to hospitals for Medicare beneficiaries who fail to pay their cost-sharing obligations for treatments provided by the hospital
Client expense: Not reported · Firm income: $260,000
2019 · fourth_quarter · Health Issues
Proposed changes to Medicare hospital reimbursement policy Health care policy Proposals to strengthen the health care system and achieve Affordable Care Act (ACA) market stability 42 CFR Part 2 alignment with HIPAA H.R. 269, "Pandemic and All-Hazards Preparedness& Advancing Innovation Act" - provisions related to hospitals Funding for National Ebola Network H.R. 2740, FY 2020 Labor, HHS, Education appropriations - provisions providing funding to support a National Ebola Education and Training Center H.R. 2113, Prescription Drug Sunshine, Transparency, Accountability and Reporting (STAR) Act" - provisions related to studying rising hospital drug prices and reporting of drug costs H.R. 965/S. 340, CREATES Act Additional legislative proposals to address rising drug costs H.R. 1559, "340B Protection and Accountability Act" Additional legislative proposals modifying the 340B program Surprise Billing S. 1895, Lower health Care Cost Act" H.R. 3630, "No Surprises Act" S. 1531, "STOP Surprise Medical Bills Act"
Client expense: $325,590 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · third_quarter · Health Issues
Continued implementation of ACA Health care policy 42 CFR Part 2 alignment with HIPAA H.R. 2113, Prescription Drug Sunshine, Transparency, Accountability and Reporting (STAR) Act" - provisions related to studying rising hospital drug prices and reporting of drug costs H.R. 965/S. 340, CREATES Act Additional legislative proposals to address rising drug costs H.R. 1559, "340B Protection and Accountability Act" Additional legislative proposals modifying the 340B program S. 1895, Lower Health Care Cost Act"- provisions related to surprise billing and payer/provider contracts S. 1531, "STOP Surprise Medical Bills Act" H.R. 3630, "No Surprises Act" H.R. 3502, "Protecting People from Surprise Medical Bills Act"
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · third_quarter · Health Issues
Health care payment and delivery system reform Health information technology and implementation of EHR meaningful use Policy related to health exchange risk corridors and cost-sharing reduction payments 42 CFR Part 2 alignment with HIPAA H.R. 269, "Pandemic and All-Hazards Preparedness& Advancing Innovation Act" - provisions related to hospitals H.R. 2113, Prescription Drug Sunshine, Transparency, Accountability and Reporting (STAR) Act" - provisions related to studying rising hospital drug prices and reporting of drug costs H.R. 965/S.340, CREATES Act Additional legislative proposals to address rising drug costs S. 1895, Lower Health Care Cost Act"- provisions related to surprise billing and payer/provider contracts S. 1531, "STOP Surprise Medical Bills Act" H.R. 3630 "No Surprises Act" H.R. 1559, "340B Protection and Accountability Act" Additional legislative proposals modifying the 340B program
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · third_quarter · Health Issues
Proposed changes to Medicare hospital reimbursement policy Health care policy Proposals to strengthen the health care system and achieve Affordable Care Act (ACA) market stability 42 CFR Part 2 alignment with HIPAA H.R. 269, "Pandemic and All-Hazards Preparedness& Advancing Innovation Act" - provisions related to hospitals Funding for National Ebola Network H.R. 2740, FY 2020 Labor, HHS, Education appropriations - provisions providing funding to support a National Ebola Education and Training Center H.R. 2113, Prescription Drug Sunshine, Transparency, Accountability and Reporting (STAR) Act" - provisions related to studying rising hospital drug prices and reporting of drug costs H.R. 965/S. 340, CREATES Act Additional legislative proposals to address rising drug costs H.R. 1559, "340B Protection and Accountability Act" Additional legislative proposals modifying the 340B program Surprise Billing S. 1895, Lower health Care Cost Act" H.R. 3630, "No Surprises Act" S. 1531, "STOP Surprise Medical Bills Act"
Client expense: Not reported · Firm income: $110,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · third_quarter · Health Issues
Health care policy H.R. 1559, "340B Protection and Accountability Act" Additional legislative proposals modifying the 340B program
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · third_quarter · Health Issues
Proposed changes to Medicare hospital reimbursement policy Health care policy 42 CFR Part 2 alignment with HIPAA H.R. 986/S. 466 Protecting Americans with Preexisting Conditions Act of 2019, a bill provide that certain guidance related to waivers for State innovation under the ACA shall have no force or effect H.R. 2113, Prescription Drug Sunshine, Transparency, Accountability and Reporting (STAR) Act" - provisions related to studying rising hospital drug prices and reporting of drug costs H.R. 965/S. 340, "CREATES Act" H.R. 938, Bringing Low-cost Options and Competition while Keeping Incentives for New Generics Act of 2019 or the BLOCKING Act of 2019 - provisions related to eligibility for approval of a subsequent generic drug and to remove the barrier to that approval posed by the 180-day exclusivity period afforded to a first generic applicant that has not yet received final approval H.R. 1499 Protecting Consumer Access to Generic Drugs Act of 2019 - provisions related to prohibiting brand name drug manufacturers from compensating generic drug manufacturers to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable product manufacturers to delay entry of biosimilar and interchangeable products Additional legislative proposals to address rising drug costs H.R. 1559, "340B Protection and Accountability Act" Additional legislative proposals modifying the 340B program S.1895, Lower Health Care Costs Act- provisions related to surprise billing and provider/payer agreements S. 1531, "STOP Surprise Medical Bills Act" H.R. 3630, "No Surprises Act" Other proposals to address surprise billing Proposals to strengthen the health care system and achieve ACA market stability
Client expense: Not reported · Firm income: $50,000
2019 · third_quarter · Medicare/Medicaid
Legislative and Administrative monitoring and outreach on issues related to Medicare. Legislative and Administrative monitoring and outreach on issues related to 340B programs. H.R. 1559, 340B Protection and Accountability Act of 2019. H.R. 1384, Medicare for All Act of 2019. S. 1129, Medicare for All Act of 2019.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · third_quarter · Health Issues
Legislative and Administrative monitoring and outreach on issues related to health care. Legislative and Administrative monitoring and outreach on issues related to 340B programs. H.R. 1559, 340B Protection and Accountability Act of 2019. S. 1895, Lower Health Care Costs Act. H.R. 1384, Medicare for All Act of 2019. S. 1129, Medicare for All Act of 2019.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · third_quarter · Medicare/Medicaid
HR1384 Medicare for All Act of 2019 (all sections of full text)(oppose) Monitored HR 275 Medicare Prescription Drug Price Negotiation Act of 2019 Monitored HR 2000 Medicare-X Choice Act of 2019 Monitored 981 Medicare-X Choice Act of 2019 Monitored S 470 Medicare at 50 Act Monitored HR1301 The Mental Health Telemedicine Expansion Act of 2019 Monitored HR1559 The 340B Protection and Accountability Act of 2019 Monitored HR1332 The Fair Care Act of 2019 Monitored CMS regulations and reporting requirements under the Emergency Medical Treatment and Labor Act Monitored proposed reduction on the amount of Medicare bad debt/uncompensated care payments to hospitals for Medicare beneficiaries who fail to pay their cost sharing obligations for treatments provided by the hospital Monitored CMS proposed rule regarding revisions to Medicare OPPS Program
Client expense: Not reported · Firm income: $40,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE